(Q39685600)

14 September 2017

1 reference

title

The epidemiology of Pseudomonas cepacia in patients with cystic fibrosis (English)

1 reference

14 September 2017

0 references

1 reference

Pseudomonas cepacia

1 reference

O C Tablan

1

1 reference

14 September 2017

W J Martone

series ordinal

2

1 reference

14 September 2017

W R Jarvis

series ordinal

3

1 reference

14 September 2017

language of work or name

1 reference

1 December 1987

1 reference

European Journal of Epidemiology

14 September 2017

1 reference

14 September 2017

3

1 reference

14 September 2017

4

1 reference

14 September 2017

336-342

1 reference

https://scigraph.springernature.com/pub.10.1007/bf00145642

14 September 2017

0 references

cites work

In Vitro Susceptibility of Pseudomonas cepacia and Pseudomonas maltophilia to Trimethoprim and Trimethoprim-Sulfamethoxazole

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF00145642

Synergistic effect of combinations of sulfamethoxazole, trimethoprim, and colistin against Pseudomonas maltophilia and Pseudomonas cepacia

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF00145642

Current status of Pseudomonas cepacia typing systems

21 January 2018

1 reference

12 December 2020

Pseudomonas cepacia strains isolated from water reservoirs of unheated nebulizers

1 reference

12 December 2020

Susceptibility of 324 Nonfermentative Gram-Negative Rods to 6 Cephalosporins and Azthreonam

1 reference

12 December 2020

Newly diagnosed cystic fibrosis in middle and later life

1 reference

12 December 2020

Imipenem/cilastatin in acute pulmonary exacerbations of cystic fibrosis

1 reference

12 December 2020

Bacterial contamination of aerosol solutions used to treat cystic fibrosis

1 reference

12 December 2020

Aerosol Polymyxin and Pneumonia in Seriously Ill Patients

1 reference

12 December 2020

Serological types of Diplococcus pneumoniae isolated from the respiratory tract of children with cystic fibrosis and children with other diseases

1 reference

12 December 2020

Comparative in-vitro activity of ciprofloxacin against non-fermenters.

1 reference

12 December 2020

Antibiotic prophylaxis in cystic fibrosis: inhaled cephaloridine as an adjunct to oral cloxacillin

1 reference

12 December 2020

A 5 YEAR CLINICAL EVALUATION OF A THERAPEUTIC PROGRAM FOR PATIENTS WITH CYSTIC FIBROSIS.

1 reference

12 December 2020

The flora of the respiratory tract of patients with cystic fibrosis of the pancreas

1 reference

12 December 2020

Pseudomonas colonization in cystic fibrosis. A study of 160 patients

1 reference

12 December 2020

The epidemiology of nosocomial Pseudomonas cepacia infections: endemic infections

1 reference

12 December 2020

Perspectives in Cystic Fibrosis

1 reference

12 December 2020

Long-term study of one hundred five patients with cystic fibrosis; studies made over a five- to fourteen-year period

1 reference

12 December 2020

Association of respiratory viral infections with pulmonary deterioration in patients with cystic fibrosis.

1 reference

12 December 2020

A simplified cystic fibrosis scoring system (a preliminary report)

1 reference

12 December 2020

In vitro activity of imipenem--a review

1 reference

12 December 2020

In vitro activity of azthreonam, a monobactam antibiotic

1 reference

12 December 2020

Colonization by Enterobacteriaceae of the respiratory tract of children with cystic fibrosis of the pancreas and their antibody response

1 reference

12 December 2020

Effect of nutrient depletion on sensitivity of Pseudomonas cepacia to phagocytosis and serum bactericidal activity at different temperatures.

1 reference

12 December 2020

Infection control in pulmonary function laboratories

1 reference

12 December 2020

Pseudomonas cepacia colonization in patients with cystic fibrosis: risk factors and clinical outcome

1 reference

12 December 2020

Alternate-day prednisone reduces morbidity and improves pulmonary function in cystic fibrosis.

1 reference

12 December 2020

Pseudomonas cepacia in the hospital setting: lack of transmission between cystic fibrosis patients

1 reference

12 December 2020

Antibiotic sensitivity of two Aeromonas and nine Pseudomonas species

1 reference

12 December 2020

Guideline for isolation precautions in hospitals

1 reference

12 December 2020

In vitro activities of aztreonam, piperacillin, and ticarcillin combined with amikacin against amikacin-resistant Pseudomonas aeruginosa and P. cepacia isolates from children with cystic fibrosis

1 reference

12 December 2020

Characterization of Pseudomonas cepacia isolates from patients with cystic fibrosis.

1 reference

12 December 2020

Pneumonia and septicemia due to Pseudomonas cepacia in a patient with cystic fibrosis

1 reference

12 December 2020

Colonization of the respiratory tract with Pseudomonas cepacia in cystic fibrosis. Risk factors and outcomes

1 reference

12 December 2020

Epidemiological investigations of the respiratory tract bacteriology in patients with cystic fibrosis

1 reference

12 December 2020

In vitro activity of BMY-28142 against pediatric pathogens, including isolates from cystic fibrosis sputum

1 reference

12 December 2020

Pseudomonas cepacia: decrease in colonization in patients with cystic fibrosis

1 reference

12 December 2020

Bacterial Flora of Respiratory Tract in Patients with Cystic Fibrosis, 1950-1971

1 reference

12 December 2020

Inhaled antibiotics in cystic fibrosis: is there a therapeutic effect?

1 reference

12 December 2020

In vitro antimicrobial activity of cefotaxime, a new cephalosporin

1 reference

12 December 2020

1 reference

12 December 2020

The epidemiology of nosocomial epidemic Pseudomonas cepacia infections

1 reference

12 December 2020

Virulence of different Pseudomonas species in a burned mouse model: tissue colonization by Pseudomonas cepacia

1 reference

12 December 2020

Occurrence and antimicrobial susceptibility of gram-negative nonfermentative bacilli in cystic fibrosis patients

1 reference

12 December 2020

Efficacy of inhaled tobramycin in the treatment of pulmonary exacerbations in children with cystic fibrosis

1 reference

12 December 2020

Sputum bacteriology in patients with cystic fibrosis in a Toronto hospital during 1970-1981

1 reference

12 December 2020

Characterization of hemolysin in extracellular products of Pseudomonas cepacia

1 reference

12 December 2020

Pseudomonas cepacia: the sensitivity of nosocomial strains to new antibiotics.

1 reference

12 December 2020

The chest roentgenogram in cystic fibrosis: a new scoring system

1 reference

12 December 2020

Importance of viruses and Legionella pneumophila in respiratory exacerbations of young adults with cystic fibrosis

1 reference

12 December 2020

Controlled trial of ceftazidime vs. ticarcillin and tobramycin in the treatment of acute respiratory exacerbations in patients with cystic fibrosis

1 reference

12 December 2020

Comparison of cefpiramide (HR-810) and four anti-pseudomonal beta-lactam agents against pseudomonas isolates from children with cystic fibrosis.

1 reference

12 December 2020

Comparative in vitro activities of third-generation cephalosporins

1 reference

12 December 2020

Mycobacterial isolations in young adults with cystic fibrosis

1 reference

12 December 2020

RESPIRATORY TRACT BACTERIOLOGY IN CYSTIC FIBROSIS

1 reference

12 December 2020

Occurrence of nonfermentative gram-negative rods other than Pseudomonas aeruginosa in the respiratory tract of children with cystic fibrosis

1 reference

12 December 2020

Pseudomonas cepacia infection in cystic fibrosis: an emerging problem

1 reference

12 December 2020

Laboratory proficiency test results on use of selective media for isolating Pseudomonas cepacia from simulated sputum specimens of patients with cystic fibrosis

1 reference

12 December 2020

Pseudomonas cepacia--fatal pulmonary infection in a patient with cystic fibrosis

1 reference

12 December 2020

Aerosol carbenicillin and gentamicin treatment of Pseudomonas aeruginosa infection in patients with cystic fibrosis

1 reference

12 December 2020

Ceftazidime therapy in patients with cystic fibrosis and multiply-drug-resistant pseudomonas.

1 reference

12 December 2020

Ceftazidime alone and in combination in patients with cystic fibrosis: lack of efficacy in treatment of severe respiratory infections caused by Pseudomonas cepacia

1 reference

12 December 2020

Combination effect of piperacillin with four aminoglycosides on nonfermenting gram-negative bacteria

1 reference

12 December 2020

Pseudomonas cepacia colonization among patients with cystic fibrosis. A new opportunist

1 reference

12 December 2020

In-vitro activity of ciprofloxacin and other antibacterial agents against Pseudomonas aeruginosa and Pseudomonas cepacia from cystic fibrosis patients

1 reference

12 December 2020

A new prognostic score and clinical evaluation system for cystic fibrosis

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00145642

1 reference

14 September 2017

1 reference